This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
RAT ANTI MOUSE CD314
catalog :
MCA6056GA
quantity :
0.1 mg
clonality :
monoclonal
host :
rat
conjugate :
nonconjugated
clone name :
CX5
reactivity :
mouse
application :
flow cytometry
product information
Entity Category :
Antibodies
Product Code :
MCA6056GA
Description :
RAT ANTI MOUSE CD314
Specificity :
CD314
Target Species :
Mouse
Host :
Rat
Format :
Purified
Isotypes :
IgG1
Applications :
F
Application Types :
Flow Cytometry
Clone :
CX5
Quantity :
0.1 mg
Quantity Value :
0.1 mg
Quantity Type :
mg
GO Accessions :
GO:0002223, GO:0016021, GO:0032394, GO:0005529, GO:0050830, GO:0009897, GO:0030101, GO:0032729, GO:0042288, GO:0045429, GO:0045954, GO:0071222
GO Terms :
activation of interferon-gamma production, activation of natural killer cell mediated cytotoxicity, activation of nitric oxide biosynthetic process, alpha-beta T cell receptor activity, cellular response to endotoxin, cellular response to LPS, defence response to Gram-positive bacteria, defence response to Gram-positive bacterium, defense response to Gram-positive bacteria, gamma-delta T cell receptor activity, Gram-positive antibacterial peptide activity, juxtamembrane, major histocompatibility complex class I binding, major histocompatibility complex class I ligand, NK cell activation, outer surface of cytoplasmic membrane, positive regulation of natural killer cell mediated cell death, positive regulation of natural killer cell mediated cell killing, positive regulation of natural killer cell mediated cytolysis, positive regulation of nitric oxide anabolism, positive regulation of nitric oxide biosynthesis, positive regulation of nitric oxide formation, positive regulation of nitric oxide synthesis, positive regulation of NK cell mediated cell death, positive regulation of NK cell mediated cell killing, positive regulation of NK cell mediated cytolysis, positive regulation of NK cell mediated cytotoxicity, positive regulation of type II interferon production, stimulation of interferon-gamma production, stimulation of natural killer cell mediated cytotoxicity, stimulation of nitric oxide biosynthetic process, stimulatory C-type lectin receptor signalling pathway, stimulatory Ly49 family receptor signaling pathway., T cell receptor activity, transmembrane, up regulation of interferon-gamma production, up regulation of natural killer cell mediated cytotoxicity, up regulation of nitric oxide biosynthetic process, up-regulation of interferon-gamma production, upregulation of interferon-gamma production, upregulation of natural killer cell mediated cytotoxicity, up-regulation of natural killer cell mediated cytotoxicity, upregulation of nitric oxide biosynthetic process, up-regulation of nitric oxide biosynthetic process
Uniprot Accessions :
O54709
Gene :
Klrk1
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=27007
EntityFormats :
Purified, RPE
UNSPSC :
41116161
Concentration :
IgG concentration 0.5 mg/ml
Product Form :
Purified IgG - liquid
PrimarySecondary :
Primary
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.